McKesson ideaShare Recognizes Excellence in Community Pharmacy
Annual Community Pharmacy Conference Featured Comprehensive Educational ProgramHealth Mart Pharmacy of the Year, Innovation Award and Lifetime Achievement Award Also Presented During the Conference (Source: McKesson News)
Source: McKesson News - June 27, 2023 Category: Information Technology Source Type: news
McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products
IRVING, TX, June 22, 2023 — McKesson, a diversified healthcare services company, today announced the launch of Foster& Thrive ™, a curated private brand of over-the-counter (OTC) health and wellness products. Launching Foster& Thrive unifies the company ’s private brand portfolio—consolidating Healt... (Source: McKesson News)
Source: McKesson News - June 22, 2023 Category: Information Technology Source Type: news
McKesson Ventures ’ Dave Schulte Named One of Healthcares Top 25 Investors
SAN FRANCISCO, June 15, 2023 — McKesson Ventures’ managing director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance, and who are recogn... (Source: McKesson News)
Source: McKesson News - June 15, 2023 Category: Information Technology Source Type: news
McKesson Releases Impact Report
IRVING, Texas, June 12, 2023 — McKesson released its latest Impact Report for fiscal years 2022 and 2023, showcasing our ongoing commitment to advancing health outcomes for all. The report details McKesson’s continued efforts to track, measure and communicate our progress in achieving our corporate ... (Source: McKesson News)
Source: McKesson News - June 14, 2023 Category: Information Technology Source Type: news
McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024
IRVING, Texas, June 13, 2023 – McKesson Corporation (NYSE:MCK) (the “Company”) today announced the pricing terms of its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”). The Tender Offer is being made pursuan... (Source: McKesson News)
Source: McKesson News - June 13, 2023 Category: Information Technology Source Type: news
McKesson Corporation Announces the Expiration and Results of Tender Offer for Any and All 3.796% Notes Due 2024
IRVING, Texas, June 13, 2023 – McKesson Corporation (NYSE:MCK) (the “Company”) today announced that its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”) expired at 5:00 p.m., New York City time, on June 13, 2... (Source: McKesson News)
Source: McKesson News - June 13, 2023 Category: Information Technology Source Type: news
McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024
IRVING, Texas, June 7, 2023 – McKesson Corporation (NYSE:MCK) (the “Company”) today announced that it has commenced an offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”). The Tender Offer is being made pursuant to the terms and sub... (Source: McKesson News)
Source: McKesson News - June 7, 2023 Category: Information Technology Source Type: news
Research Presented at ASCO 2023 Shows Implementing Value-Based Care Strategies Such as Dose Rounding Reduces Drug Waste and Total Cost of Care
THE WOODLANDS, Texas, June 5, 2023 — Principal investigators from The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, presented findings at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeti... (Source: McKesson News)
Source: McKesson News - June 5, 2023 Category: Information Technology Source Type: news
Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer
BOSTON, June 4, 2023 — Ontada®, a McKesson business dedicated to leveraging oncology real-world evidence (RWE), clinical education, and provider technology to transform the fight against cancer, presented new data at the American Society of Clinical Oncology (ASCO) Annual Meeting which showed that 7... (Source: McKesson News)
Source: McKesson News - June 4, 2023 Category: Information Technology Source Type: news
McKesson Corporation Reports Fiscal Fourth-Quarter and Full-year Results and Raises Long-Term Segment Growth Targets
Fourth-Quarter Highlights: (Source: McKesson News)
Source: McKesson News - May 8, 2023 Category: Information Technology Source Type: news
Research to Be Presented at ISPOR 2023 Illuminates the Economic Costs of Melanoma and Non-Small Cell Lung Cancer and Provides Insights That Can Help Strengthen the Quality and Approach to Real-World Evidence Generation
IRVING, TEXAS, May 5, 2023 — Ontada®, a McKesson business dedicated to leveraging oncology real-world data (RWD), real-world evidence (RWE), clinical education, and provider technology to transform the fight against cancer, will be presenting research at ISPOR 2023, The Professional Society for Hea... (Source: McKesson News)
Source: McKesson News - May 5, 2023 Category: Information Technology Source Type: news
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas, April 27, 2023 —The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on July 3, 2023, to stockholders of record on June 1, 2023. (Source: McKesson News)
Source: McKesson News - April 27, 2023 Category: Information Technology Source Type: news
Regional Cancer Care Associates Joins The US Oncology Network
THE WOODLANDS, Texas, April 6, 2023 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced that Regional Cancer Care Associates (RCCA) entered into a strategic relationship with The Network effecti... (Source: McKesson News)
Source: McKesson News - April 6, 2023 Category: Information Technology Source Type: news
McKesson ideaShare Invites Independent Community Pharmacy Teams to Annual Industry Education and Networking Event
IRVING, TX, April 5, 2023 —Registration is now open for McKesson ideaShare in Las Vegas from June 22–25, 2023. McKesson ideaShare is the nation’s premier community pharmacy annual education and networking event, hosted by McKesson, Health Mart, and Health Mart Atlas. The event returns with double the... (Source: McKesson News)
Source: McKesson News - April 5, 2023 Category: Information Technology Source Type: news
Biologics by McKesson Named the Exclusive Pharmacy for FDA- Approved SKYCLARYS (omaveloxolone) for the Treatment of Friedreich ’s Ataxia
CARY, N.C., April 5, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Reata Pharmaceuticals as the sole specialty pharmacy provider for SKYCLARYSTM (omaveloxolone), the first and only treatment for Friedreich’s ataxia (FA). S... (Source: McKesson News)
Source: McKesson News - April 5, 2023 Category: Information Technology Source Type: news
